Linsitinib (OSI-906)

linsitinib · Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Linsitinib (OSI-906), covering 2012-10-12 to 2024-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial [Phase 2]